Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Will Co-Promote Fujisawa's Mycamine With Rociphen Sales Force

This article was originally published in The Pink Sheet Daily

Executive Summary

Roche's hospital sales force will "augment" Fujisawa's promotion of the antifungal. Roche will be compensated based on product sales. Mycamine will be available within the next month, Fujisawa says.

You may also be interested in...



Astellas Seeks Mycamine Candidemia Claim With sNDA

Antifungal facing additional competition this year following approval of Pfizer, Schering-Plough products.

Astellas Seeks Mycamine Candidemia Claim With sNDA

Antifungal facing additional competition this year following approval of Pfizer, Schering-Plough products.

Rocephin Generics Ship After Roche’s Ceftriaxone Patent Expires

Roche is forecasting a "classic erosion" of its injectable antibiotic Rocephin (ceftriaxone) after patent protection expired July 19

Related Content

Topics

UsernamePublicRestriction

Register

OM013057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel